Canada Strategic Metals Announces Private Placement

equities Canada |

MONTREAL, QUEBEC--(March 11, 2015) - Canada Strategic Metals Inc. ("CS Metals" or "the Company") (CJC:CA) (FRANKFURT:YXEN) (CJCFF) announces that it is currently arranging non-brokered private placement for up of $500,000 consisting in:

- Private placement of Unit common shares

The Company is proposing to issue 5,000,000 common shares Units at a cost of $0.10 per Unit. Each Unit includes one common share at a price of $0.10 per share and one-half common share purchase warrants of the Corporation. Each warrant entitles the holder thereof to purchase one common share of the Corporation for a period of 24 months at a price of $0.15 per share.

Finders' fees of 8% of the gross proceeds of the offering may be paid in cash and in non-transferable finder's fees warrants.

The above-mentioned private placements are subject to the approval of the TSX Venture Exchange.

About Canada Strategic Metals

Canada Strategic Metals is an emerging company focused on the exploration and development of a number of projects covering over 20,000 hectares in Quebec. With broad management experience in green technology and junior resource exploration and development, Canada Strategic Metals is well positioned to aggressively advance this promising property portfolio for its shareholders.

For more information on the Company, please visit www.canadastrategicmetals.ca.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

Jean-Sebastien Lavallee, P. Geo
Chief Executive Officer
819-354-5146

Christophe Romary
President
514-913-7483
ir@canadastrategicmetals.com
www.canadastrategicmetals.com

Paradox Public Relations
514-341-0408

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

Uber

Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…

Snapwire

A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.